“Christian Haass is one of the world’s leading experts on the molecular mechanisms of Alzheimer’s disease,” said Professor Pierluigi Nicotera, Chairman of the DZNE’s Executive Board. “We owe him groundbreaking insights into proteins and immune reactions involved in Alzheimer’s disease. Christian Haass has thus laid the foundations for new approaches in therapy and diagnosis. He has played a key role in Alzheimer’s research over the past 30 years and continues to do so today.”
“With this prize we want to honor outstanding researchers on the one hand and help to get Alzheimer’s and other neurodegenerative diseases out of the taboo zone on the other hand,” said Olaf Piepenbrock, Managing Partner of the Piepenbrock Group. “Many people with Alzheimer’s are afraid to talk about their condition because they are concerned about social exclusion. In addition to better therapies, more understanding of the needs of people with Alzheimer’s is therefore required. The same applies to the needs of their relatives. Because in most cases they shoulder a considerable part of the daily care.”
Award for cutting-edge research
Since 2011, the “Hartwig Piepenbrock-DZNE Prize” has been awarded every two years for outstanding research on neurodegenerative diseases. These diseases, which include Alzheimer’s and Parkinson’s, are characterized by neuronal dysfunctions and the death of nerve cells. This may cause dementia, movement disorders or other health problems. The Prize is endowed by the Piepenbrock Group and awarded in remembrance of its former Chief Executive Officer and Chairman Hartwig Piepenbrock, who passed away after suffering from dementia. He was committed to the arts, science, and society for many years. The Prize winner is selected by an international committee, coordinated by the DZNE. This year, the Prize will be awarded for the fifth time.